Literature DB >> 29895660

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency.

Matthew M Heeney1,2,3, Dongjing Guo3, Luigia De Falco4,5, Dean R Campagna6, Gordana Olbina7, Paige P-C Kao3, Klaus Schmitz-Abe8, Fedik Rahimov9, Patrick Gutschow7, Keith Westerman7, Vaughn Ostland7, Tracy Jackson10, Robert J Klaassen10, Kyriacos Markianos6, Karin E Finberg11, Achille Iolascon4,5, Mark Westerman7, Wendy B London1,2,3, Mark D Fleming6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29895660      PMCID： PMC6071554          DOI： 10.1182/blood-2017-03-773028

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  The serine protease TMPRSS6 is required to sense iron deficiency.

Authors:  Xin Du; Ellen She; Terri Gelbart; Jaroslav Truksa; Pauline Lee; Yu Xia; Kevin Khovananth; Suzanne Mudd; Navjiwan Mann; Eva Marie Y Moresco; Ernest Beutler; Bruce Beutler
Journal:  Science       Date:  2008-05-01       Impact factor: 47.728

2.  Immunoassay for human serum hepcidin.

Authors:  Tomas Ganz; Gordana Olbina; Domenico Girelli; Elizabeta Nemeth; Mark Westerman
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

3.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).

Authors:  Karin E Finberg; Matthew M Heeney; Dean R Campagna; Yeşim Aydinok; Howard A Pearson; Kip R Hartman; Mary M Mayo; Stewart M Samuel; John J Strouse; Kyriacos Markianos; Nancy C Andrews; Mark D Fleming
Journal:  Nat Genet       Date:  2008-04-13       Impact factor: 38.330

Review 4.  Hepcidin in the diagnosis of iron disorders.

Authors:  Domenico Girelli; Elizabeta Nemeth; Dorine W Swinkels
Journal:  Blood       Date:  2016-04-04       Impact factor: 22.113

5.  Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.

Authors:  Luigia De Falco; Laura Silvestri; Caroline Kannengiesser; Erica Morán; Claire Oudin; Marco Rausa; Mariasole Bruno; Jessica Aranda; Bienvenida Argiles; Idil Yenicesu; Maria Falcon-Rodriguez; Ebru Yilmaz-Keskin; Ulker Kocak; Carole Beaumont; Clara Camaschella; Achille Iolascon; Bernard Grandchamp; Mayka Sanchez
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

6.  Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory.

Authors:  Albertine E Donker; Charlotte C M Schaap; Vera M J Novotny; Roel Smeets; Tessa M A Peters; Bert L P van den Heuvel; Martine F Raphael; Anita W Rijneveld; Inge M Appel; Andre J Vlot; A Birgitta Versluijs; Michel van Gelder; Bernd Granzen; Mirian C H Janssen; Alexander J M Rennings; Frank L van de Veerdonk; Paul P T Brons; Dirk L Bakkeren; Marten R Nijziel; L Thom Vlasveld; Dorine W Swinkels
Journal:  Am J Hematol       Date:  2016-12       Impact factor: 10.047
  6 in total
  8 in total

1.  Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors.

Authors:  Patrick Gutschow; Huiling Han; Gordana Olbina; Keith Westerman; Elizabeta Nemeth; Tomas Ganz; Karen Copeland; Mark Westerman; Vaughn Ostland
Journal:  J Appl Lab Med       Date:  2020-09-01

Review 2.  Hepcidin and Anemia: A Tight Relationship.

Authors:  Alessia Pagani; Antonella Nai; Laura Silvestri; Clara Camaschella
Journal:  Front Physiol       Date:  2019-10-09       Impact factor: 4.566

3.  Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Authors:  Joe N Frost; Tiong Kit Tan; Munawar Abbas; Sarah K Wideman; Michael Bonadonna; Nicole U Stoffel; Katherine Wray; Barbara Kronsteiner; Gaby Smits; Dean R Campagna; Tiago L Duarte; José M Lopes; Akshay Shah; Andrew E Armitage; João Arezes; Pei Jin Lim; Alexandra E Preston; David Ahern; Megan Teh; Caitlin Naylor; Mariolina Salio; Uzi Gileadi; Simon C Andrews; Susanna J Dunachie; Michael B Zimmermann; Fiona R M van der Klis; Vincenzo Cerundolo; Oliver Bannard; Simon J Draper; Alain R M Townsend; Bruno Galy; Mark D Fleming; Marie C Lewis; Hal Drakesmith
Journal:  Med (N Y)       Date:  2021-02-12

4.  Transferrin Saturation/Hepcidin Ratio Discriminates TMPRSS6-Related Iron Refractory Iron Deficiency Anemia from Patients with Multi-Causal Iron Deficiency Anemia.

Authors:  Hilde van der Staaij; Albertine E Donker; Dirk L Bakkeren; Jan M J I Salemans; Lisette A A Mignot-Evers; Marlies Y Bongers; Jeanne P Dieleman; Tessel E Galesloot; Coby M Laarakkers; Siem M Klaver; Dorine W Swinkels
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

Review 5.  Iron metabolism and iron disorders revisited in the hepcidin era.

Authors:  Clara Camaschella; Antonella Nai; Laura Silvestri
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

6.  Molecular analysis of homeostatic iron regulator, transmembrane protease serine-6, and BTB domain-containing protein-9 variants and iron parameters in blood donors.

Authors:  Manal S Fawzy; Abeer Fakhr-Eldeen; Baraah T Abu AlSel; Eman A Toraih
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

7.  The <em>TMPRSS6</em> variant (SNP rs855791) affects iron metabolism and oral iron absorption - a stable iron isotope study in Taiwanese women.

Authors:  Simone Buerkli; Sung-Nan Pei; Shu-Chen Hsiao; Chien-Te Lee; Christophe Zeder; Michael B Zimmermann; Diego Moretti
Journal:  Haematologica       Date:  2021-11-01       Impact factor: 9.941

8.  Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation.

Authors:  Jiaxin Zhao; Yanyan Xu; Jingyuan Xie; Junling Liu; Ruiyan Zhang; Xiaoxiang Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-08-05       Impact factor: 8.311
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.